Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are tolerable drugs used for patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC). Serious adverse reactions are uncommon compared with cytotoxic drugs. CASE SUMMARY: A 52-year-old man presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, So-My, Kim, Ki-Up, Kim, Yang-Ki, Uh, Soo-Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409203/
https://www.ncbi.nlm.nih.gov/pubmed/34540979
http://dx.doi.org/10.12998/wjcc.v9.i24.7205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409203/
https://www.ncbi.nlm.nih.gov/pubmed/34540979
http://dx.doi.org/10.12998/wjcc.v9.i24.7205

Ejemplares similares